← Back to Search

Euploid embryo transfer group for Female Infertility (SLEEP Trial)

N/A
Recruiting
Led By Jessica Walter, MD, MSCE
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sleep parameters will be measured on a daily basis. pregnancy outcomes will be measured at time of pregnancy testing, and if positive up to 8-10 weeks of gestation
Awards & highlights

SLEEP Trial Summary

Sleep is a critical component of daily life that significantly influences health and well-being. Despite the integral role sleep plays in life, its effect on women's reproductive health, and its subsequent impact on fertility, is largely understudied. The purpose of the SLEEP Study is to investigate the link between sleep and fertility. Participants will use a wireless wearable device mounted on the finger to measure sleep in the weeks preceding and following an embryo transfer during treatment with in vitro fertilization. The investigators hope that these findings will inform future therapies that improve sleep and fertility outcomes.

Eligible Conditions
  • Female Infertility

SLEEP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~sleep parameters will be measured on a daily basis
This trial's timeline: 3 weeks for screening, Varies for treatment, and sleep parameters will be measured on a daily basis for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of sleep on IVF outcomes
Secondary outcome measures
Effect of anxiety on sleep parameters
Effect of depression on sleep parameters
Effect of frozen embryo transfer protocol type on sleep parameters and pregnancy outcomes

SLEEP Trial Design

1Treatment groups
Experimental Treatment
Group I: Euploid embryo transfer groupExperimental Treatment1 Intervention
Participants will wear the Oura Ring continuously for data collection starting in the month prior to their embryo transfer date. They will wear the Oura Ring throughout the preparation, embryo transfer, and post-transfer until either a negative pregnancy test or, if positive, until 8 weeks gestation. The study time for each participant will thus extend from either 5 weeks for negative pregnancy tests, to 10 weeks for normally continuing pregnancies.

Find a Location

Who is running the clinical trial?

Friends of PrenticeOTHER
3 Previous Clinical Trials
554 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,081 Total Patients Enrolled
Jessica Walter, MD, MSCEPrincipal InvestigatorNorthwestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
~100 spots leftby Jan 2025